← Back to Patent Explorer
US3723619A Expired / Lapsed US ⏱️ 0.0 years remaining

Diuretic and saluretic compositions and method with 3-tertiary amino propionyl-benzofuran-2-carboxylic acids

Assignee: Novartis Corp
•
Filing: 1970-11-18
•
Granted: 1973-03-27
•
Expires: 1990-11-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract 5-(2-Di(lower)alkylaminomethyl-(lower)alkanoyl)-benzofuran-2carboxylic acids and their pharmaceutically acceptable salts with acids and bases are prepared by Mannich condensation of 5-loweralkanoyl-substituted benzofuran-2-carboxylic acids with paraformaldehyde and secondary amines. A typical embodiment is 5-(2dimethylaminomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid hydrochloride. A method of producing a diuretic and a saluretic effect comprising administration of said compounds to warm-blooded animals as well as pharmaceutical compositions containing said compounds are provided.

Inventors

  • 👤 J Zergenyi
  • 👤 E Habicht

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-06 13:41
CPC Classifications
C; C07; C07D; C07D307/00; C07D307/77; C07D307/78; C07D307/82; C07D307/84; C07D307/85

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 12 words
A method according to claim 1 wherein said compound is 5-(2-dimethylaminomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 2
Dependent Claim 12 words
A method according to claim 1 wherein said compound is 5-(2-piperidinomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 3
Dependent Claim 12 words
A method according to claim 1 wherein said compound is 5-(2-morpholinomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 4
Dependent Claim 12 words
A method according to claim 1 wherein said compound is 5-(2-dimethylaminomethyl-propionyl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 5
Dependent Claim 40 words
A pharmaceutical composition comprising a combination in dosage unit fOrm of a pharmaceutical carrier and an amount sufficient to produce a diuretic and a saluretic effect upon administration of said dosage unit form of a compound of the Formula I
Claim 6
Dependent Claim 12 words
A composition according to claim 6 wherein said compound is 5-(2-dimethylaminomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 7
Dependent Claim 12 words
A composition according to claim 6 wherein said compound is 5-(2-piperidinomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 8
Dependent Claim 12 words
A composition according to claim 6 wherein said compound is 5-(2-morpholinomethyl-butyryl)-6-methyl-benzofuran-2-carboxylic acid.
Claim 9
Dependent Claim 12 words
A composition according to claim 6 wherein said compound is 5-(2-dimethylaminomethyl-propionyl)-6-methyl-benzofuran-2-carboxylic acid.

References Cited (Backward Citations)

US3551458A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1976-03-26 1976-09-25 1977-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1980-03-26 1980-09-25 1981-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1984-03-26 1984-09-25 1985-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag